Moneycontrol
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Strides Pharma Science

Strides Pharma Science

BSE: 532531|NSE: STAR|ISIN: INE939A01011|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 26, 16:00
410.05
-6.45 (-1.55%)
VOLUME 200,937
LIVE
NSE
May 26, 15:59
410.00
-6.5 (-1.56%)
VOLUME 556,691
News on Strides Pharma Science
Select Year: 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy Strides Pharma Science; target of Rs 421: ICICI Securities

9.54 pm | 25 May 2020 |  Source: Moneycontrol.com

ICICI Securities is bullish on Strides Pharma Science has recommended buy rating on the stock with a target price of Rs 421 in its research report dat...

Strides Pharma Consolidated March 2020 Net Sales at Rs 618.64 crore, up 0.4% Y-o-Y

9.13 am | 21 May 2020 |  Source: Moneycontrol.com

NULL...

Strides Pharma to export antiviral tablets for COVID-19, share price rises 11%

10.24 am | 29 Apr 2020 |  Source: Moneycontrol.com

The company has developed Favipiravir tablets in 400mg and 200mg strengths for convenient dosage administration....

Strides Pharma Standalone December 2019 Net Sales at Rs 364.47 crore, down 12.11% Y-o-Y

12.30 pm | 31 Jan 2020 |  Source: Moneycontrol.com

NULL...

Strides Pharma Consolidated December 2019 Net Sales at Rs 732.44 crore, down 7.81% Y-o-Y

10.50 am | 31 Jan 2020 |  Source: Moneycontrol.com

NULL...

Strides Pharma Standalone December 2019 Net Sales at Rs 364.47 crore, down 12.11% Y-o-Y

2.18 pm | 30 Jan 2020 |  Source: Moneycontrol.com

NULL...

Strides Pharma Consolidated December 2019 Net Sales at Rs 732.44 crore, down 7.81% Y-o-Y

2.08 pm | 30 Jan 2020 |  Source: Moneycontrol.com

NULL...

Strides Pharma Science Q3 net declines 69% to Rs 92cr

12.52 pm | 30 Jan 2020 |  Source: PTI

However, the consolidated income of the company increased to Rs 744.66 crore in the October-December period, as against Rs 579.54 crore a year ago....

Strides Pharma Science Q3 profit rises 358%

9.59 am | 30 Jan 2020 |  Source: Moneycontrol.com

Earnings before interest, tax, depreciation and amortisation (EBITDA) was up 184 percent at Rs 185.1 crore against Rs 65 crore....

1 2
Quick Links for Strides Pharma Science
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.